February 1, 2022
Deadline for submitting an application.
We accept applications for the 2022-23 academic year by February 1, 11:59 PM.
March 1, 2022
The results of the substantive review will be announced. Selected candidates will receive invitations for interviews. The Selection Committee plans to qualify max. 60 candidates.
The invited candidates will have to submit an additional document indicating max. two projects from each host institution (8 in total) with justifications for their selection. This selection of projects is not final and can be changed during the interview. If there is a large number of highly-rated candidates, an alternate list will be created.
March 5, 2022
Deadline for submitting a transcript from the Fall 2021 semester for candidates selected for interviews and evidence of having a booster shot prior to interviews, or commit to having a booster shot by the time the interview takes place in mid-March.
March 10-20, 2022
Interviews.
Unless there are special circumstances, the interviews will be conducted in person in Warsaw and/or any other selected by the Selection Committee city. In the event that travel is impossible, the interviews will be conducted remotely using ZOOM and the schedule will be set up by the Fulbright Commission.
The Selection Committee consists of the representatives of host institutions (Prof. Zygmunt Derewenda – University of Virginia, Prof. Anthony Kossiakoff – University of Chicago, Prof. Jose Rizo-Rey – University of Texas Southwestern Medical Center and Dr Umesh Deshmukh – Oklahoma Medical Research Foundation).
There are 35-45 positions (this number may change). If all positions are not filled after the first round of interviews, additional interviews for candidates on the alternate list may be organized. In such a case, these additional interviews will take place March 25-30.
April 15
Preliminary results, placement process.
End of April
Final results with the placements’ approval.
Mid-May
Pre-departure orientation in Warsaw or online.
Late June-Early July
Departure to the U.S.